Madrigal Pharmaceuticals (MDGL) Total Debt Growth (1y) (2011 - 2026)
Madrigal Pharmaceuticals (MDGL) Total Debt Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 103.99% |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 3.84% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.07% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Madrigal Pharmaceuticals | 15.77 Bn | 15.54 Bn | - | 188.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 188.40% |
| Dec 31, 2025 | 189.09% |
| Sep 30, 2025 | 190.17% |
| Jun 30, 2025 | 1.52% |
| Mar 31, 2025 | 1.61% |
| Dec 31, 2024 | 1.81% |
| Sep 30, 2024 | -21.36% |
| Jun 30, 2024 | 17.49% |
| Mar 31, 2024 | 2.15% |
| Dec 31, 2023 | 134.29% |
| Sep 30, 2023 | 203.96% |
| Jun 30, 2023 | 103.92% |
| Jun 30, 2016 | -99.89% |
| Mar 31, 2016 | -80.04% |
| Dec 31, 2015 | -66.67% |
| Sep 30, 2015 | -57.12% |
| Jun 30, 2015 | -49.95% |
| Mar 31, 2015 | -44.56% |
| Dec 31, 2014 | -40.61% |
| Sep 30, 2014 | -31.42% |